Pharmaceutical traceability and supply chain SaaS solutions provider LSPedia announced on Wednesday that it has received the MMCAP Infuse DSCSA Compliance contract, the company's second major United States government contract.

This follows its national DSCSA contract with the US Department of Veterans Affairs, further solidifying LSPedia's leadership position in the US pharmaceutical supply chain.

MMCAP Infuse is a healthcare group purchasing organisation that provides contracts for medical supplies, pharmaceuticals, services and compliance solutions. Through this contract, MMCAP Infuse's 17,000+ member facilities -- including hospitals, correctional facilities and public health clinics -- gain access to LSPedia's traceability solution to ensure seamless FDA DSCSA compliance, enhance patient safety and automate pharmacy workflows. In addition, LSPedia's EHR, WMS and PMS integrations eliminate redundant scanning and manual data entry, saving each facility hours of manual process receiving and reconciliation, freeing pharmacists and technicians to focus on patient care and revenue-generating activities.

Daniel MacKinnon, LSPedia SVP of Sales and Marketing, said: "Hospitals and healthcare facilities need more than just DSCSA compliance; they need a solution that enhances efficiency and strengthens their bottom line. With this contract, MMCAP Infuse members gain access to the best-in-class tools to streamline operations, reduce administrative burdens and focus on what matters most -- delivering exceptional patient care."